← Open Payments lookup

OSCAR ESCOBAR: Open Payments

NPI 1477670750 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$308 in 14 payments from 9 companies in 2025. Trend: 2023 $980 · 2024 $440 · 2025 $308

Food & beverage: $308
CompanyPaymentsAmount
Lilly USA, LLC5$131
ABBVIE INC.2$34
Paratek Pharmaceuticals, Inc.1$30
Amgen Inc.1$29
Xeris Pharmaceuticals, Inc.1$21
GlaxoSmithKline, LLC.1$17
Cranial Technologies, Inc1$17
Novo Nordisk Inc1$16
SHIELD THERAPEUTICS INC1$15

Products named: MOUNJARO, XHANCE, Repatha, GVOKE HYPOPEN, UBRELVY, TRELEGY ELLIPTA, Doc Band, Wegovy.

Industry payments across CA — which companies pay providers there.